| Prevention of iatrogenic anemia in critical and neonatal care. N Jakacka, E Snarski, S Mekuria Advances in Clinical and Experimental Medicine: Official Organ Wroclaw …, 2016 | 56 | 2016 |
| The impact of cytogenetic evolution and acquisition of del (17p) on the prognosis of patients with multiple myeloma. A Salomon-Perzyński, A Bluszcz, A Krzywdzińska, Z Spyra-Gorny, ... Polish Archives of Internal Medicine 130 (6), 483-491, 2020 | 8 | 2020 |
| Tracking clonal evolution of multiple myeloma using targeted next-generation DNA sequencing A Salomon-Perzyński, J Barankiewicz, M Machnicki, ... Biomedicines 10 (7), 1674, 2022 | 3 | 2022 |
| Safety and Efficacy Results from CLI120-001 a Phase 1 Study in RR-AML and HR-MDS: Update from Higher Dose Levels EL Marańda, E Patkowska, N Jakacka, CN Abboud, HA Burris, ... Blood 142, 2913, 2023 | | 2023 |
| Evaluation of the immune response against SARS-CoV-2 in a group of patients with secondary immunodeficiency in hematooncological diseases after administration of two doses of … A Cieloch, P Laskowska, P Mrówka, A Mroczek, N Jakacka, K Wiśniewski, ... Acta Haematologica Polonica 53, 2022 | | 2022 |
| Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma: Real-World Report of Polish Lymphoma Research Group E Paszkiewicz-Kozik, M Debowska, N Jakacka, M Kotarska, M Szymanski, ... Chemotherapy 67 (4), 201-210, 2022 | | 2022 |
| The impact of cytogenetic evolution and acquisition of del (17p) on the prognosis of multiple myeloma patients A Salomon-Perzyński, A Bluszcz, A Krzywdzińska, Z Spyra-Górny, ... Polish Archives of Internal Medicine, 2020 | | 2020 |
| Inhibitory czynnika Xa w sytuacjach szczególnych M Solarska, P Wyleżoł, N Jakacka, M Postuła, DA Kosior Kardiologia w Praktyce 9 (2), 26-30, 2015 | | 2015 |
